SlideShare une entreprise Scribd logo
1  sur  54
Télécharger pour lire hors ligne
Prof. Shaikh Abusufiyan
Part-01:Patient Compliance
Pharma Learning
At the end of this e-learning session you are able to…
A. Define patient Non-compliance.
B. Discuss effect of poor compliance, method
of assessment and reasons for non-compliance.
2
l Safe and effective drug therapy occurs
when patients are well informed about
their medications and their use.
l Well inform patients exhibit:
- Increase compliance with drug regimens
Result in improved therapeutic outcomes
l Therefore, pharmacist and other health care professionals have a
responsibility --> to properly inform patients about their drug
therapy.
Non-compliance
l When patient does not follow the treatment schedule suggested
by the physician for the management of illness
he is described as non-compliant.
l Non compliant behaviour
also encompasses failure to obey instructions on:
- Diet
- Exercise
- Smoking or drinking habits.
l Degree of non compliance is expressed as a % of the ideal
compliance:
% compliance= NDP - NME * 100
NDP
l Where, NDP = No of doses prescribed
NME= No of medication error
Effect of Poor Compliance
l Poor compliance have serious effect in some
disease conditions:
- Non compliance with anticonvulsant therapy -->
contributes to uncontrolled seizures
- Omission of few doses of insulin --> may be life
threatening.
- Unintentional overdose result in --> toxicity,
serious enough to require hospitalisation.
Q&A
Q.1 When safe and effective drug therapy
occur?
Q.2 Enlist few effects of poor compliance.
8
Method of assessment of compliance
1. Interrogation:
l With the use of standard questionnaire:
- it is possible to assess the compliance
level and aspects such as:
- inconvenience of the regimen
- incidence of SE
- and overall level of comprehension.
2. Residual Tablet Counting:
- Tablet count can be performed on
regular basis and comparative no of
used tab over a period can be noted
down.
Disadvantage:
l Such methods are subjective and
inaccurate.
3. Urine analysis:
- Ex. Urine marker like riboflavin --> may be added in the
dosage regimen and its presence in the urine --> may be
noted for more accurate assessment of compliance.
4. Drug analysis:
- Specific and sensitive methods ----> to detect potent
therapeutic agent in body fluids, like digoxin and phenytoin.
l Cpss = F * D
Cl * T
l Cpss = Steady state concentration
F= Bioavailability
D= Dose administered
T= Dosage interval
Cl= Drug clearance
l The dose input rate (FD/T) may be
calculated as:
FD/T= Cpss * Cl
l Determination of plasma conc. of the
drug ---> give most accurate and
direct indication of the dose
administered.
Reference:
q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd
edition. Carrier Publication Pg. No:86-105.
Q&A
Quiz-Attendance/Feedback:
https:/
/forms.gle/2zhTaYATheRTLQhG9
1
5
6
Prof. Shaikh Abusufiyan
Part-02:Patient Compliance
Pharma Learning
At the end of this e-learning session you are able to…
A. Explain the reason for patient Non-compliance.
B. Discuss strategies to overcome patient non-
compliance.
8
Reasons for Non-compliance
l The reason for non compliant behaviour --> are complex and cannot be generalised.
l Almost every patient --> is potential defaulter.
Reasons:
1. Poor standards of labelling:
- Label on medication containers must be clear and specific.
- Many patients do not understand common labelling instructions
ex. “Take as required” or “use as directed”
- Poorly hand written labels with bad hand writing are a major source of
medication error.
2. Inappropriate packing:
- Many elderly patients have difficulty
in opening the container --> specially
if size is too small or cap is difficult
to unscrew.
- The blister pack may be --> too rigid
- Glass bottle may be very fragile --->
making handling difficult
3. Complex therapeutic regimen:
- In case where patient have to take 25-30 different drugs at varying
time interval during day
Dosage regimens are difficult to memorize and lead to unintentional
non-compliance.
4. Nature of medication:
- Preparation with an unpleasant taste, colour or odour
- Extremely small tab ---> difficult to identify and handle
- Very large tab ---> difficult to swallow
- Liquid dosage form ---> difficult to transport
- Irritational side effect
5.Deliberate deviation:
- Once patient begin to feel better --> treatment may be stopped.
- Improper or insufficient advise --> given to patients
- At a time, lack of proper physician–pharmacist rapport
may also be responsible for non- compliant behaviour.
- Some time due to mental diseases -->
patient may forget to take an
occasional dose of medication.
- Doses may be completely omitted or
duplicated due to forgetfulness
Q&A
Q.1 Give one example of how poor standards of labelling
may be responsible for patient non-compliance?
Q.2 In which case patient non-compliance is due to
deliberate deviation?
5
Strategies for Improving Compliance
1. Simplification of the therapeutic regimen:
• Minimizing the complexity of therapeutic regimens
• Physician must prescribe a minimum number of drugs with well
define dosage schedules.
• Once daily dosage may be recommended whenever possible
(Sustained release, long acting oral preparation)
2. Improving standard of dispensing practice:
• Appropriate container size
can be selected
to accommodate a label, bearing dosage instructions
2. Improving standard of dispensing practice:
q Dosing Instructions must be:
• precise, explicit and large
• easily ridable
• Most satisfying container for elderly is palm
sized transparent bottle with standard soft
plastic screw cap.
• Child resistant containers should be used with
discretion.
3. Development of suitable
medication packaging:
- Packaging in general should help self
monitoring of drug intake.
- Ex. Blister or unit dose packaging
q Medication box: which is divided into
sections --> according to the days of the
week.
q Individual drugs are given in
compartments --> corresponding to the
time of administration. NEW START UP IDEA
https://www.dreamit.com/journal/fell
ow-launches-connected-pillbox
4. Supplementary Labelling:
q Supplementary labelling instructions --> are
recommended to convey important data
regarding drug administration.
q The information may include:
l Precaution or recommendation
l Description of drug action.
l Supplementary Labelling:
l Symbol or graphics --> may be used to
emphasise the correct time of
administration.
l A 'daily calendar' or a tablet
identification card --> bearing details of
the administration schedule may be given
to improve compliance.
Reference:
q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd
edition. Carrier Publication Pg. No:86-105.
Q&A
Quiz-Attendance/Feedback:
https:/
/forms.gle/sjRvLKEd9EUUV3466
3
4
5
Prof. Shaikh Abusufiyan
Part-03:Patient Compliance
Pharma Learning
At the end of this e-learning session you are able to…
A. Explain role of patient counselling for improving
patient compliance.
B. Demonstrate the knowledge of precautions, directions
for medications & administration instructions to improve
patient compliance.
7
Patient counselling and education
q The pharmacist should inform, educate
and counsel the patient about:
l Name
l Intended use and expected action
l Route, dosage form, administration schedule
l Special direction for preparation if any
l Precaution to be observed during administration
l Common SE
l Technique for self monitoring of drug therapy
l Storage
• Potential drug-drug or drug-food interaction
• Prescription refill information
• Action to be taken in the event of missed dose
• Selection of non prescription drug i.e OTC drug
l Depend on the type and extend of advice needed.
l It can be given in following forms:
1. Verbal counselling
2. Printed information including
o Warning card
o Individualised medication instruction sheets
o Leaflets and booklets describing drugs and
disease conditions
o Patient package insert given by manufacturer
The method of imparting patient education and counselling
3. In patient medication training program
4. Compliance clinics --> to educate patient
identified to be non-compliant.
l The pharmacist with good communication
skill and practical experience --> can
counsel the patients
q The routine counselling of all patients is
both undesirable and impractical.
q Priority should be given to cases where:
§ Prophylactic treatment
§ Drug with low safety margin (ex. Warfarin)
§ Premature withdrawal from treatment (ex.
Corticosteroids)
§ Long term therapy (for a chronic condition) (ex.
epilepsy)
Q&A
Q.1 Which information pharmacist impart to patient as
a part of patient counseling & education?
Q.2 What are different methods of imparting patient
education and counselling?
Q.3 In which case priority is given to patient
counselling?
3
Important think that is to be kept in mind???????
q Information should be conveyed in
a manner in which:
• The patient can understand and
comprehend.
• Common language and familiar term
should be used in a style which is
reassuring rather than threatening.
Precautions and Directions for Medications and
Administration Instructions
l It is to be conveyed to the patient by the Pharmacist.
IT WILL HELP TO
Reduce no of patients who do not take their prescribed
medication correctly
q Disease state:
• Type of counselling and degree of
instructions ----> influenced by the
particular disease state.
• Extend of counselling is depend on --->
the severity and risk factors.
q Attention should be drawn to:
l Precautions
l Indications and contraindications
l Adverse reactions
l Drug interaction
l And sign and symptoms to watch for promoting
safe use of drug
Ex. Diabetes patient must understand:
§ Important of maintaining treatment
schedule.
§ Proper diet and precaution in taking other
medicines.
§ Necessary storage precaution for the insulin
§ Need of sterile syringe.
q OTC products:
• Purchased even without consulting doctor.
• Pharmacist must help patient in selection of
OTC products
• Ex. Aspirin, Antacids and Vitamins
q Pharmacist must ensure their proper use by asking questions like:
§ “Are you aware that excessive use of
l antacids can lead to alkalosis?
l Laxative can lead to loss of intestinal tone?
• Or “if you are a cardiac patient”:
l do you know that high content of alkali is undesirable for your
condition and that you have to be on low salt diet?
q Printed drug information:
• Oral instructions are recommended to be
reinforced with additional printed information.
• Patient taking special categories of drugs
such as anti-coagulant and MAO inhibitors
should be given warning cards at the time of
dispensing
Reference:
q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd
edition. Carrier Publication Pg. No:86-105.
Q&A
Quiz-Attendance/Feedback:
https:/
/forms.gle/1mSf6hijNyRYmLD6A
5
3
4

Contenu connexe

Tendances

Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery System
Dr Gajanan Sanap
 

Tendances (20)

Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Multicompartment Models
Multicompartment ModelsMulticompartment Models
Multicompartment Models
 
Prescribed Medication Order and Communication Skills.pptx
Prescribed Medication Order and Communication Skills.pptxPrescribed Medication Order and Communication Skills.pptx
Prescribed Medication Order and Communication Skills.pptx
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
Factors affecting absorption of drugs
Factors affecting absorption of drugsFactors affecting absorption of drugs
Factors affecting absorption of drugs
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification system
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
ICH guidelines (Q,S,E,M)
ICH guidelines (Q,S,E,M)ICH guidelines (Q,S,E,M)
ICH guidelines (Q,S,E,M)
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery System
 
Investigational use of drugs
Investigational use of drugsInvestigational use of drugs
Investigational use of drugs
 
Cpm ppt
Cpm pptCpm ppt
Cpm ppt
 
Measurement of medication adherence
Measurement of medication  adherenceMeasurement of medication  adherence
Measurement of medication adherence
 
Estimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersEstimation of pharmacokinetic parameters
Estimation of pharmacokinetic parameters
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery System
 
Indian Regulatory Requirements
Indian Regulatory RequirementsIndian Regulatory Requirements
Indian Regulatory Requirements
 
Regulatory requirement for drug approval
Regulatory requirement for drug approvalRegulatory requirement for drug approval
Regulatory requirement for drug approval
 
Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II
 
Community Pharmacy Management
Community Pharmacy ManagementCommunity Pharmacy Management
Community Pharmacy Management
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
 

Similaire à Patient compliance and assessment |Method of Assessment | Strategy to reduce patient non-compliance | Role of Pharmacist to Improve Patient Compliance

Similaire à Patient compliance and assessment |Method of Assessment | Strategy to reduce patient non-compliance | Role of Pharmacist to Improve Patient Compliance (20)

Patient compliance Pdf
Patient compliance PdfPatient compliance Pdf
Patient compliance Pdf
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
patientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdfpatientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdf
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Patient Counselling
Patient CounsellingPatient Counselling
Patient Counselling
 
16 ab1t0022
16 ab1t002216 ab1t0022
16 ab1t0022
 
medication adherence
medication adherencemedication adherence
medication adherence
 
Clinical Pharmacy - Patient Compliance
Clinical Pharmacy - Patient ComplianceClinical Pharmacy - Patient Compliance
Clinical Pharmacy - Patient Compliance
 
Compliance
ComplianceCompliance
Compliance
 
clinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docxclinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docx
 
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.
 
PATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdfPATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdf
 
PHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docxPHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docx
 
PATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLSPATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLS
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
 
Medication Adherence.pdf
Medication Adherence.pdfMedication Adherence.pdf
Medication Adherence.pdf
 
patient consuling.
patient consuling.patient consuling.
patient consuling.
 
RDP-PP-MA.pdf
RDP-PP-MA.pdfRDP-PP-MA.pdf
RDP-PP-MA.pdf
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 

Plus de Shaikh Abusufyan

PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptxPHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
Shaikh Abusufyan
 
antiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfantiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdf
Shaikh Abusufyan
 
Neurohumoral Transmission.pdf
Neurohumoral Transmission.pdfNeurohumoral Transmission.pdf
Neurohumoral Transmission.pdf
Shaikh Abusufyan
 
Drug Excretion.pdf
Drug Excretion.pdfDrug Excretion.pdf
Drug Excretion.pdf
Shaikh Abusufyan
 
Anthelmintics drugs.pdf
Anthelmintics drugs.pdfAnthelmintics drugs.pdf
Anthelmintics drugs.pdf
Shaikh Abusufyan
 
Drug Distribution.pdf
Drug Distribution.pdfDrug Distribution.pdf
Drug Distribution.pdf
Shaikh Abusufyan
 
Absorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdfAbsorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdf
Shaikh Abusufyan
 
Anti-fungal drugs.pdf
Anti-fungal drugs.pdfAnti-fungal drugs.pdf
Anti-fungal drugs.pdf
Shaikh Abusufyan
 
Agonists and Antagonist.pdf
Agonists and Antagonist.pdfAgonists and Antagonist.pdf
Agonists and Antagonist.pdf
Shaikh Abusufyan
 
Macrolides.pdf
Macrolides.pdfMacrolides.pdf
Macrolides.pdf
Shaikh Abusufyan
 
Chemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfChemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdf
Shaikh Abusufyan
 
CHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfCHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdf
Shaikh Abusufyan
 
Routs of drug administration.pptx
Routs of drug administration.pptxRouts of drug administration.pptx
Routs of drug administration.pptx
Shaikh Abusufyan
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
Shaikh Abusufyan
 
Nasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfNasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdf
Shaikh Abusufyan
 
Antibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfAntibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdf
Shaikh Abusufyan
 

Plus de Shaikh Abusufyan (20)

PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptxPHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
 
antiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfantiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdf
 
Neurohumoral Transmission.pdf
Neurohumoral Transmission.pdfNeurohumoral Transmission.pdf
Neurohumoral Transmission.pdf
 
Drug Excretion.pdf
Drug Excretion.pdfDrug Excretion.pdf
Drug Excretion.pdf
 
Anthelmintics drugs.pdf
Anthelmintics drugs.pdfAnthelmintics drugs.pdf
Anthelmintics drugs.pdf
 
Drug metabolism.pdf
Drug metabolism.pdfDrug metabolism.pdf
Drug metabolism.pdf
 
Drug Distribution.pdf
Drug Distribution.pdfDrug Distribution.pdf
Drug Distribution.pdf
 
Absorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdfAbsorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdf
 
Anti-fungal drugs.pdf
Anti-fungal drugs.pdfAnti-fungal drugs.pdf
Anti-fungal drugs.pdf
 
Agonists and Antagonist.pdf
Agonists and Antagonist.pdfAgonists and Antagonist.pdf
Agonists and Antagonist.pdf
 
Macrolides.pdf
Macrolides.pdfMacrolides.pdf
Macrolides.pdf
 
Chemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfChemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdf
 
CHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfCHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdf
 
Routs of drug administration.pptx
Routs of drug administration.pptxRouts of drug administration.pptx
Routs of drug administration.pptx
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
 
Nasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfNasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdf
 
Antibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfAntibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdf
 
Adverse drug reactions.pdf
Adverse drug reactions.pdfAdverse drug reactions.pdf
Adverse drug reactions.pdf
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 

Dernier

Dernier (20)

Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 

Patient compliance and assessment |Method of Assessment | Strategy to reduce patient non-compliance | Role of Pharmacist to Improve Patient Compliance

  • 1. Prof. Shaikh Abusufiyan Part-01:Patient Compliance Pharma Learning
  • 2. At the end of this e-learning session you are able to… A. Define patient Non-compliance. B. Discuss effect of poor compliance, method of assessment and reasons for non-compliance. 2
  • 3. l Safe and effective drug therapy occurs when patients are well informed about their medications and their use. l Well inform patients exhibit: - Increase compliance with drug regimens Result in improved therapeutic outcomes
  • 4. l Therefore, pharmacist and other health care professionals have a responsibility --> to properly inform patients about their drug therapy. Non-compliance l When patient does not follow the treatment schedule suggested by the physician for the management of illness he is described as non-compliant.
  • 5. l Non compliant behaviour also encompasses failure to obey instructions on: - Diet - Exercise - Smoking or drinking habits.
  • 6. l Degree of non compliance is expressed as a % of the ideal compliance: % compliance= NDP - NME * 100 NDP l Where, NDP = No of doses prescribed NME= No of medication error
  • 7. Effect of Poor Compliance l Poor compliance have serious effect in some disease conditions: - Non compliance with anticonvulsant therapy --> contributes to uncontrolled seizures - Omission of few doses of insulin --> may be life threatening. - Unintentional overdose result in --> toxicity, serious enough to require hospitalisation.
  • 8. Q&A Q.1 When safe and effective drug therapy occur? Q.2 Enlist few effects of poor compliance. 8
  • 9. Method of assessment of compliance 1. Interrogation: l With the use of standard questionnaire: - it is possible to assess the compliance level and aspects such as: - inconvenience of the regimen - incidence of SE - and overall level of comprehension.
  • 10. 2. Residual Tablet Counting: - Tablet count can be performed on regular basis and comparative no of used tab over a period can be noted down. Disadvantage: l Such methods are subjective and inaccurate.
  • 11. 3. Urine analysis: - Ex. Urine marker like riboflavin --> may be added in the dosage regimen and its presence in the urine --> may be noted for more accurate assessment of compliance. 4. Drug analysis: - Specific and sensitive methods ----> to detect potent therapeutic agent in body fluids, like digoxin and phenytoin.
  • 12. l Cpss = F * D Cl * T l Cpss = Steady state concentration F= Bioavailability D= Dose administered T= Dosage interval Cl= Drug clearance
  • 13. l The dose input rate (FD/T) may be calculated as: FD/T= Cpss * Cl l Determination of plasma conc. of the drug ---> give most accurate and direct indication of the dose administered.
  • 14. Reference: q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd edition. Carrier Publication Pg. No:86-105.
  • 16. 6
  • 17. Prof. Shaikh Abusufiyan Part-02:Patient Compliance Pharma Learning
  • 18. At the end of this e-learning session you are able to… A. Explain the reason for patient Non-compliance. B. Discuss strategies to overcome patient non- compliance. 8
  • 19. Reasons for Non-compliance l The reason for non compliant behaviour --> are complex and cannot be generalised. l Almost every patient --> is potential defaulter. Reasons: 1. Poor standards of labelling: - Label on medication containers must be clear and specific. - Many patients do not understand common labelling instructions ex. “Take as required” or “use as directed” - Poorly hand written labels with bad hand writing are a major source of medication error.
  • 20. 2. Inappropriate packing: - Many elderly patients have difficulty in opening the container --> specially if size is too small or cap is difficult to unscrew. - The blister pack may be --> too rigid - Glass bottle may be very fragile ---> making handling difficult
  • 21. 3. Complex therapeutic regimen: - In case where patient have to take 25-30 different drugs at varying time interval during day Dosage regimens are difficult to memorize and lead to unintentional non-compliance.
  • 22. 4. Nature of medication: - Preparation with an unpleasant taste, colour or odour - Extremely small tab ---> difficult to identify and handle - Very large tab ---> difficult to swallow - Liquid dosage form ---> difficult to transport - Irritational side effect
  • 23. 5.Deliberate deviation: - Once patient begin to feel better --> treatment may be stopped. - Improper or insufficient advise --> given to patients - At a time, lack of proper physician–pharmacist rapport may also be responsible for non- compliant behaviour.
  • 24. - Some time due to mental diseases --> patient may forget to take an occasional dose of medication. - Doses may be completely omitted or duplicated due to forgetfulness
  • 25. Q&A Q.1 Give one example of how poor standards of labelling may be responsible for patient non-compliance? Q.2 In which case patient non-compliance is due to deliberate deviation? 5
  • 26. Strategies for Improving Compliance 1. Simplification of the therapeutic regimen: • Minimizing the complexity of therapeutic regimens • Physician must prescribe a minimum number of drugs with well define dosage schedules. • Once daily dosage may be recommended whenever possible (Sustained release, long acting oral preparation)
  • 27. 2. Improving standard of dispensing practice: • Appropriate container size can be selected to accommodate a label, bearing dosage instructions
  • 28. 2. Improving standard of dispensing practice: q Dosing Instructions must be: • precise, explicit and large • easily ridable • Most satisfying container for elderly is palm sized transparent bottle with standard soft plastic screw cap. • Child resistant containers should be used with discretion.
  • 29. 3. Development of suitable medication packaging: - Packaging in general should help self monitoring of drug intake. - Ex. Blister or unit dose packaging
  • 30. q Medication box: which is divided into sections --> according to the days of the week. q Individual drugs are given in compartments --> corresponding to the time of administration. NEW START UP IDEA https://www.dreamit.com/journal/fell ow-launches-connected-pillbox
  • 31. 4. Supplementary Labelling: q Supplementary labelling instructions --> are recommended to convey important data regarding drug administration. q The information may include: l Precaution or recommendation l Description of drug action.
  • 32. l Supplementary Labelling: l Symbol or graphics --> may be used to emphasise the correct time of administration. l A 'daily calendar' or a tablet identification card --> bearing details of the administration schedule may be given to improve compliance.
  • 33. Reference: q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd edition. Carrier Publication Pg. No:86-105.
  • 35. 5
  • 36. Prof. Shaikh Abusufiyan Part-03:Patient Compliance Pharma Learning
  • 37. At the end of this e-learning session you are able to… A. Explain role of patient counselling for improving patient compliance. B. Demonstrate the knowledge of precautions, directions for medications & administration instructions to improve patient compliance. 7
  • 38. Patient counselling and education q The pharmacist should inform, educate and counsel the patient about: l Name l Intended use and expected action l Route, dosage form, administration schedule l Special direction for preparation if any
  • 39. l Precaution to be observed during administration l Common SE l Technique for self monitoring of drug therapy l Storage • Potential drug-drug or drug-food interaction • Prescription refill information • Action to be taken in the event of missed dose • Selection of non prescription drug i.e OTC drug
  • 40. l Depend on the type and extend of advice needed. l It can be given in following forms: 1. Verbal counselling 2. Printed information including o Warning card o Individualised medication instruction sheets o Leaflets and booklets describing drugs and disease conditions o Patient package insert given by manufacturer The method of imparting patient education and counselling
  • 41. 3. In patient medication training program 4. Compliance clinics --> to educate patient identified to be non-compliant. l The pharmacist with good communication skill and practical experience --> can counsel the patients
  • 42. q The routine counselling of all patients is both undesirable and impractical. q Priority should be given to cases where: § Prophylactic treatment § Drug with low safety margin (ex. Warfarin) § Premature withdrawal from treatment (ex. Corticosteroids) § Long term therapy (for a chronic condition) (ex. epilepsy)
  • 43. Q&A Q.1 Which information pharmacist impart to patient as a part of patient counseling & education? Q.2 What are different methods of imparting patient education and counselling? Q.3 In which case priority is given to patient counselling? 3
  • 44. Important think that is to be kept in mind??????? q Information should be conveyed in a manner in which: • The patient can understand and comprehend. • Common language and familiar term should be used in a style which is reassuring rather than threatening.
  • 45. Precautions and Directions for Medications and Administration Instructions l It is to be conveyed to the patient by the Pharmacist. IT WILL HELP TO Reduce no of patients who do not take their prescribed medication correctly
  • 46. q Disease state: • Type of counselling and degree of instructions ----> influenced by the particular disease state. • Extend of counselling is depend on ---> the severity and risk factors.
  • 47. q Attention should be drawn to: l Precautions l Indications and contraindications l Adverse reactions l Drug interaction l And sign and symptoms to watch for promoting safe use of drug
  • 48. Ex. Diabetes patient must understand: § Important of maintaining treatment schedule. § Proper diet and precaution in taking other medicines. § Necessary storage precaution for the insulin § Need of sterile syringe.
  • 49. q OTC products: • Purchased even without consulting doctor. • Pharmacist must help patient in selection of OTC products • Ex. Aspirin, Antacids and Vitamins
  • 50. q Pharmacist must ensure their proper use by asking questions like: § “Are you aware that excessive use of l antacids can lead to alkalosis? l Laxative can lead to loss of intestinal tone? • Or “if you are a cardiac patient”: l do you know that high content of alkali is undesirable for your condition and that you have to be on low salt diet?
  • 51. q Printed drug information: • Oral instructions are recommended to be reinforced with additional printed information. • Patient taking special categories of drugs such as anti-coagulant and MAO inhibitors should be given warning cards at the time of dispensing
  • 52. Reference: q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd edition. Carrier Publication Pg. No:86-105.
  • 54. 4